GlycoMimetics Inc
NASDAQ:GLYC

Watchlist Manager
GlycoMimetics Inc Logo
GlycoMimetics Inc
NASDAQ:GLYC
Watchlist
Price: 0.2288 USD -4.67% Market Closed
Market Cap: 14.8m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+346%
Revenue
Forecast
N/A
Operating Income
Forecast
-8%
Net Income
Forecast
+62%

Wall Street
Price Targets

GLYC Price Targets Summary
GlycoMimetics Inc

Wall Street analysts forecast GLYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLYC is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

GLYC Lowest Forecast
Wall Street Target
1.01 USD
341% Upside
GLYC Average Forecast
Wall Street Target
1.02 USD
346% Upside
GLYC Highest Forecast
Wall Street Target
1.05 USD
359% Upside
Lowest
Price Target
1.01 USD
341% Upside
Average
Price Target
1.02 USD
346% Upside
Highest
Price Target
1.05 USD
359% Upside
GlycoMimetics Inc Competitors:
Price Targets
ALDX
Aldeyra Therapeutics Inc
284% Upside
TNGX
Tango Therapeutics Inc
447% Upside
4593
Healios KK
5% Upside
ABBV
Abbvie Inc
17% Upside
ALDX
Aldeyra Therapeutics Inc
284% Upside
TNGX
Tango Therapeutics Inc
447% Upside
4593
Healios KK
5% Upside
ABBV
Abbvie Inc
17% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
48% Upside
AVTE
Aerovate Therapeutics Inc
11% Downside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
8% Upside
302440
SK Bioscience Co Ltd
7% Upside

Revenue
Forecast

Revenue Estimate
GlycoMimetics Inc

For the last 8 years the compound annual growth rate for GlycoMimetics Inc's revenue is -61%.

-61%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
GlycoMimetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
GlycoMimetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
What are analyst estimates?

See Also

Summary
GLYC intrinsic value, competitors valuation, and company profile.
DCF Valuation
GLYC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GLYC stock valuation using valuation multiples.
Wall Street Estimates
GLYC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GLYC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GLYC's stock price target?
Price Target
1.02 USD

According to Wall Street analysts, the average 1-year price target for GLYC is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.